In Brief: Nicox Extends Cash Runway As Kowa Advances NCX 470 In Japan

H2 Start For Phase III Trial

 
• By Sushmita Panda
  
Asia ophthalmology
Kowa advances Nicox's ocular hypertension candidate in Japan (Shutterstock)

More from Clinical Trials

More from Therapy Areas